| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.072 | 0.2 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |